AN2 Therapeutics
ANTX
#9442
Rank
$31.63 M
Marketcap
$1.06
Share price
0.95%
Change (1 day)
-92.88%
Change (1 year)

AN2 Therapeutics (ANTX) - Cash on Hand

Cash on Hand as of June 2024 : $0.10 Billion USD

According to AN2 Therapeutics's latest financial reports the company has $0.10 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AN2 Therapeutics - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$96.05 M64.05%
2021-12-31$58.55 M1338.7%
2020-12-31$4.07 M